Works matching Topoisomerase inhibitors

Results: 1709

Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells.

Published in:

Cellular Oncology (2211-3428), 2018, v. 41, n. 2, p. 201, doi. 10.1007/s13402-017-0366-0

By:

Wasim, Lubna;
Chopra, Madhu

Publication type:

Article

Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors.

Published in:

Biochemistry (00062979), 2023, v. 88, n. 7, p. 892, doi. 10.1134/S0006297923070040

By:

Lomov, Nikolai A.;
Viushkov, Vladimir S.;
Rubtsov, Mikhail A.

Publication type:

Article

Seconeolitsine, the Novel Inhibitor of DNA Topoisomerase I, Protects against Invasive Pneumococcal Disease Caused by Fluoroquinolone-Resistant Strains.

Published in:

Antibiotics (2079-6382), 2021, v. 10, n. 5, p. 573, doi. 10.3390/antibiotics10050573

By:

Tirado-Vélez, Jose Manuel;
Carreño, David;
Sevillano, David;
Alou, Luis;
Yuste, José;
de la Campa, Adela G.;
Simal-Gandara, Jesus

Publication type:

Article

MHY440, a Novel Topoisomerase Ι Inhibitor, Induces Cell Cycle Arrest and Apoptosis via a ROS-Dependent DNA Damage Signaling Pathway in AGS Human Gastric Cancer Cells.

Published in:

Molecules, 2019, v. 24, n. 1, p. 96, doi. 10.3390/molecules24010096

By:

Jang, Jung Yoon;
Kang, Yong Jung;
Sung, Bokyung;
Kim, Min Jeong;
Park, Chaeun;
Kang, Dongwan;
Moon, Hyung Ryong;
Chung, Hae Young;
Kim, Nam Deuk;
Tuccinardi, Tiziano

Publication type:

Article

CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer.

Published in:

Molecular Medicine, 2019, v. 25, n. 1, p. N.PAG, doi. 10.1186/s10020-019-0089-y

By:

Lee, Sungha;
Ho, Jung Yoon;
Liu, Jing Jing;
Lee, Hyewon;
Park, Jae Young;
Baik, Minwha;
Ko, Minji;
Lee, Seon Ui;
Choi, Youn Jin;
Hur, Soo Young

Publication type:

Article

Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors.

Published in:

BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2925-6

By:

Pawlak, Alicja;
Ziolo, Ewa;
Fiedorowicz, Anna;
Fidyt, Klaudyna;
Strzadala, Leon;
Kalas, Wojciech

Publication type:

Article

Discovery of 7-Methyl-10-Hydroxyhomocamptothecins with 1,2,3-Triazole Moiety as Potent Topoisomerase I Inhibitors.

Published in:

Chemical Biology & Drug Design, 2016, v. 88, n. 3, p. 398, doi. 10.1111/cbdd.12767

By:

Xu, Xiguo;
Wu, Yuelin;
Liu, Wenfeng;
Sheng, Chuanquan;
Yao, Jianzhong;
Dong, Guoqiang;
Fang, Kun;
Li, Jin;
Yu, Zhiliang;
Min, Xiao;
Zhang, Huojun;
Miao, Zhenyuan;
Zhang, Wannian

Publication type:

Article

Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.

Published in:

2021

By:

Wang, Airong;
Li, Lingling;
Li, Mengya;
Wang, Shujuan;
Wang, Chong

Publication type:

Correction Notice

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.

Published in:

Pharmaceuticals (14248247), 2023, v. 16, n. 2, p. 261, doi. 10.3390/ph16020261

By:

Grossman, Scott;
Fishwick, Colin W. G.;
McPhillie, Martin J.

Publication type:

Article

Molecular Docking studies and in-silico ADMET Screening of Some novel Oxazine substituted 9-Anilinoacridines as Topoisomerase II Inhibitors.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2017, v. 51, n. 1, p. 110, doi. 10.5530/ijper.51.1.15

By:

Kalirajan, Rajagopal;
Sankar, Sundaram;
Jubie, Selvaraj;
Gowramma, Byran

Publication type:

Article

Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.

Published in:

Pathology & Oncology Research, 2019, v. 25, n. 1, p. 59, doi. 10.1007/s12253-017-0312-5

By:

Aaberg-Jessen, Charlotte;
Fogh, Louise;
Sørensen, Mia Dahl;
Halle, Bo;
Brünner, Nils;
Kristensen, Bjarne Winther

Publication type:

Article

MSN8C: A Promising Candidate for Antitumor Applications as a Novel Catalytic Inhibitor of Topoisomerase II.

Published in:

Molecules, 2023, v. 28, n. 14, p. 5598, doi. 10.3390/molecules28145598

By:

Ou, Jie-Bin;
Huang, Wei-Hao;
Liu, Xing-Zi;
Dai, Guo-Yao;
Wang, Lu;
Huang, Zhi-Shu;
Huang, Shi-Liang

Publication type:

Article

Design and in silico Prediction of New Methylenedioxyphenyl Derivatives as DNA Topoisomerase II Inhibitors.

Published in:

International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 548, doi. 10.5530/ijpi.13.3.068

By:

Rathore, Swati;
Reddemma, Maadhu;
Rai, Neha;
Tiwari, Richa Tripathy;
Begum, Shaheen;
Patil, Shailendra;
Patil, Asmita Gajbhiye

Publication type:

Article

DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors.

Published in:

Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05133-7

By:

Li, Xi;
Yao, Jun;
Qu, Chen;
Luo, Lan;
Li, Bing;
Zhang, Yu;
Zhu, Zhongyuan;
Qiu, Yang;
Hua, Haiqing

Publication type:

Article

Developing a Phosphospecific IHC Assay as a Predictive Biomarker for Topoisomerase I Inhibitors.

Published in:

Journal of Histochemistry & Cytochemistry, 2018, v. 66, n. 8, p. 549, doi. 10.1369/0022155418766503

By:

Ando, Koji;
Tohme, Yara Hamade;
Srinivasiah, Adithi;
Taylor-Parker, Julian;
Harrington, Yevgeniya;
Shah, Ankur K.;
Oki, Eiji;
Brahmandam, Mohan;
Bharti, Ajit K.

Publication type:

Article

Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1015, doi. 10.1007/s00280-015-2722-y

By:

Muzzio, Miguel;
Hu, Shu-Chieh;
Holleran, Julianne;
Parise, Robert;
Eiseman, Julie;
Yellow-Duke, Archibong;
Covey, Joseph;
Glaze, Elizabeth;
Engelke, Kory;
Egorin, Merrill;
McCormick, David;
Beumer, Jan

Publication type:

Article

The DNA topoisomerase II inhibitor amsacrine as a novel candidate adjuvant in a model of glaucoma filtration surgery.

Published in:

Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55365-7

By:

Yamamoto, Kotaro;
Kokubun, Taiki;
Sato, Kota;
Akaishi, Takahiro;
Shimazaki, Atsushi;
Nakamura, Masatsugu;
Shiga, Yukihiro;
Tsuda, Satoru;
Omodaka, Kazuko;
Saya, Hideyuki;
Nakazawa, Toru

Publication type:

Article

Novel Bacterial Topoisomerase Inhibitors Exploit Asp83 and the Intrinsic Flexibility of the DNA Gyrase Binding Site.

Published in:

International Journal of Molecular Sciences, 2018, v. 19, n. 2, p. 453, doi. 10.3390/ijms19020453

By:

Franco-Ulloa, Sebastian;
La Sala, Giuseppina;
Miscione, Gian Pietro;
De Vivo, Marco

Publication type:

Article

Synthesis and biological evaluation of new derivatives of tricyclic heteroaromatic carboxamides as potential topoisomerase I inhibitors.

Published in:

Ukrainica Bioorganica Acta, 2016, v. 14, n. 1, p. 3

By:

Kostina, V. G.;
Alexeeva, I. V.;
Lysenko, N. A.;
Negrutska, V. V.;
Dubey, I. Ya.

Publication type:

Article

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.

Published in:

Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.633142

By:

Matias-Barrios, Victor M.;
Radaeva, Mariia;
Song, Yi;
Alperstein, Zaccary;
Lee, Ahn R.;
Schmitt, Veronika;
Lee, Joseph;
Ban, Fuqiang;
Xie, Ning;
Qi, Jianfei;
Lallous, Nada;
Gleave, Martin E.;
Cherkasov, Artem;
Dong, Xuesen

Publication type:

Article

The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.

Published in:

PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132052

By:

Wu, Chun-Chi;
Huang, Keh-Feng;
Yang, Tsung-Ying;
Li, Ya-Ling;
Wen, Chi-Luan;
Hsu, Shih-Lan;
Chen, Tzu-Hsiu

Publication type:

Article

Antibacterial activity of a DNA topoisomerase I inhibitor versus fluoroquinolones in Streptococcus pneumoniae.

Published in:

PLoS ONE, 2020, v. 15, n. 11, p. N.PAG, doi. 10.1371/journal.pone.0241780

By:

Valenzuela, Myriam V.;
Domenech, Mirian;
Mateos-Martínez, Patricia;
González-Camacho, Fernando;
de la Campa, Adela G.;
García, Maria Teresa

Publication type:

Article

DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising safety profile and therapeutic efficacy in preclinical small cell lung cancer models.

Published in:

Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05568-y

By:

Lin, Shengchao;
Zhang, Yu;
Yao, Jun;
Yang, Junjie;
Qiu, Yang;
Zhu, Zhongyuan;
Hua, Haiqing

Publication type:

Article

Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.

Published in:

Microbiology & Immunology, 2016, v. 60, n. 4, p. 253, doi. 10.1111/1348-0421.12372

By:

Nukuzuma, Souichi;
Nakamichi, Kazuo;
Kameoka, Masanori;
Sugiura, Shigeki;
Nukuzuma, Chiyoko;
Tasaki, Takafumi;
Takegami, Tsutomu

Publication type:

Article

cGAS/STING axis mediates a topoisomerase II inhibitor-induced tumor immunogenicity.

Published in:

2019

By:

Zining Wang;
Jiemin Chen;
Jie Hu;
Hongxia Zhang;
Feifei Xu;
Wenzhuo He;
Xiaojuan Wang;
Mengyun Li;
Wenhua Lu;
Gucheng Zeng;
Penghui Zhou;
Peng Huang;
Siyu Chen;
Wende Li;
Liang-ping Xia;
Xiaojun Xia;
Wang, Zining;
Chen, Jiemin;
Hu, Jie;
Zhang, Hongxia

Publication type:

journal article

Nostocine A Derivatives as Human DNA Topoisomerase II-alpha Inhibitor.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, n. 3, p. 698, doi. 10.5530/ijper.54.3.120

By:

Sahoo, Chita Ranjan;
Paidesetty, Sudhir Kumar;
Padhy, Rabindra Nath

Publication type:

Article

Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors.

Published in:

Molecules, 2022, v. 27, n. 3, p. 1009, doi. 10.3390/molecules27031009

By:

Liu, Jin-Chuan;
Chen, Bo;
Yang, Jia-Lin;
Weng, Jian-Quan;
Yu, Qian;
Hu, De-Xuan

Publication type:

Article

Synthesis and evaluation of original bioisosteres of bacterial type IIA topoisomerases inhibitors.

Published in:

Canadian Journal of Chemistry, 2016, v. 94, n. 3, p. 240, doi. 10.1139/cjc-2015-0475

By:

Petrella, Stéphanie;
Aubry, Alexandra;
Janvier, Geneviève;
Coutant, Eloi P.;
Cartier, Alex;
Dao, Thuy-Ha;
Bonhomme, Frédéric J.;
Motreff, Laurence;
Pissis, Cédric;
Bizet, Chantal;
Clermont, Dominique;
Begaud, Evelyne;
Retailleau, Pascal;
Munier-Lehmann, Hélène;
Capton, Estelle;
Mayer, Claudine;
Janin, Yves L.

Publication type:

Article

Case Report: 7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.664176

By:

Wang, Airong;
Li, Lingling;
Li, Mengya;
Wang, Shujuan;
Wang, Chong

Publication type:

Article

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2171029

By:

Farouk, Faten;
Elmaaty, Ayman Abo;
Elkamhawy, Ahmed;
Tawfik, Haytham O.;
Alnajjar, Radwan;
Abourehab, Mohammed A. S.;
Saleh, Mohamed A.;
Eldehna, Wagdy M.;
Al‐Karmalawy, Ahmed A.

Publication type:

Article

Design and synthesis of novel rigid dibenzo[b,f]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2022.2157825

By:

El-Behairy, Mohammed Farrag;
Abd-Allah, Walaa Hamada;
Khalifa, Mohamed M.;
Nafie, Mohamed S.;
Saleh, Mohamed A.;
Abdel-Maksoud, Mohammed S.;
Al-Warhi, Tarfah;
Eldehna, Wagdy M.;
Al‐Karmalawy, Ahmed A.

Publication type:

Article

Identification of the first-in-class dual inhibitors of human DNA topoisomerase IIα and indoleamine-2,3-dioxygenase 1 (IDO 1) with strong anticancer properties.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 192, doi. 10.1080/14756366.2022.2140420

By:

Kaproń, Barbara;
Płazińska, Anita;
Płaziński, Wojciech;
Plech, Tomasz

Publication type:

Article

From Antarctica to cancer research: a novel human DNA topoisomerase IB inhibitor from Antarctic sponge Dendrilla antarctica.

Published in:

Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1404, doi. 10.1080/14756366.2022.2078320

By:

Ottaviani, Alessio;
Welsch, Joshua;
Agama, Keli;
Pommier, Yves;
Desideri, Alessandro;
Baker, Bill J.;
Fiorani, Paola

Publication type:

Article

MOLECULAR DOCKING STUDIES ON SOME BENZAMIDE DERIVATIVES AS TOPOISOMERASE INHIBITORS.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2020, v. 44, n. 3, p. 470, doi. 10.33483/jfpau.789537

By:

YILMAZ, Serap;
ATAEI, Sanaz;
YILDIZ, İlkay

Publication type:

Article

Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.

Published in:

Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0304-z

By:

Turner, Joel G.;
Dawson, Jana L.;
Grant, Steven;
Shain, Kenneth H.;
Dalton, William S.;
Yun Dai;
Meads, Mark;
Baz, Rachid;
Kauffman, Michael;
Shacham, Sharon;
Sullivan, Daniel M.

Publication type:

Article

BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer.

Published in:

2006

By:

Nagashima, Seiji;
Soda, Hiroshi;
Oka, Mikio;
Kitazaki, Takeshi;
Shiozawa, Ken;
Nakamura, Yoichi;
Takemura, Masaaki;
Yabuuchi, Hikaru;
Fukuda, Minoru;
Tsukamoto, Kazuhiro;
Kohno, Shigeru

Publication type:

journal article

High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer.

Published in:

Cancers, 2022, v. 14, n. 1, p. 2, doi. 10.3390/cancers14010002

By:

Flörkemeier, Inken;
Steinhauer, Tamara N.;
Hedemann, Nina;
Weimer, Jörg Paul;
Rogmans, Christoph;
van Mackelenbergh, Marion T.;
Maass, Nicolai;
Clement, Bernd;
Bauerschlag, Dirk O.

Publication type:

Article

Immunogenic Cell Death by the Novel Topoisomerase I Inhibitor TLC388 Enhances the Therapeutic Efficacy of Radiotherapy.

Published in:

Cancers, 2021, v. 13, n. 6, p. 1218, doi. 10.3390/cancers13061218

By:

Huang, Kevin Chih-Yang;
Chiang, Shu-Fen;
Yang, Pei-Chen;
Ke, Tao-Wei;
Chen, Tsung-Wei;
Hu, Ching-Han;
Huang, Yi-Wen;
Chang, Hsin-Yu;
Chen, William Tzu-Liang;
Chao, K. S. Clifford;
Arenas, Meritxell;
Franco, Pierfrancesco

Publication type:

Article

Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines.

Published in:

Journal of Neuro-Oncology, 2010, v. 99, n. 2, p. 201, doi. 10.1007/s11060-010-0127-7

By:

Sarcar, Bhaswati;
Kahali, Soumen;
Chinnaiyan, Prakash

Publication type:

Article

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059896

By:

Flörkemeier, Inken;
Steinhauer, Tamara N.;
Hedemann, Nina;
Ölander, Magnus;
Artursson, Per;
Clement, Bernd;
Bauerschlag, Dirk O.

Publication type:

Article

Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure.

Published in:

Journal of Negative Results in Biomedicine, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1477-5751-13-11

By:

Kischlat Lacombe, Otto;
Araujo Zuma, Aline;
da Silva, Camila Cristina;
de Souza, Wanderley;
Motta, Maria Cristina M.

Publication type:

Article

Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells.

Published in:

Cancer Immunology, Immunotherapy, 2011, v. 60, n. 1, p. 133, doi. 10.1007/s00262-010-0926-x

By:

Haggerty, Timothy;
Dunn, Ian;
Rose, Lenora;
Newton, Estelle;
Martin, Sunil;
Riley, James;
Kurnick, James

Publication type:

Article

Toxicological evaluation of the topoisomerase inhibitor, etoposide, in the model animal Caenorhabditis elegans and 3T3-L1 normal murine cells.

Published in:

Environmental Toxicology, 2017, v. 32, n. 6, p. 1836, doi. 10.1002/tox.22406

By:

Lee, So Young;
Kim, Joo Yeon;
Jung, Yu‐Jin;
Kang, Kyungsu

Publication type:

Article

Current Role of Topoisomerase I Inhibitors for the Treatment of Mesenchymal Malignancies and Their Potential Future Use as Payload of Sarcoma-Specific Antibody-Drug Conjugates.

Published in:

Oncology Research & Treatment, 2024, v. 47, n. 1/2, p. 18, doi. 10.1159/000535491

By:

Schöffski, Patrick;
Wang, Chao-Chi;
Schöffski, Morris Patrick;
Wozniak, Agnieszka

Publication type:

Article

Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211059896

By:

Flörkemeier, Inken;
Steinhauer, Tamara N.;
Hedemann, Nina;
Ölander, Magnus;
Artursson, Per;
Clement, Bernd;
Bauerschlag, Dirk O.

Publication type:

Article

Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomyces flavoviridis.

Published in:

World Journal of Microbiology & Biotechnology, 2014, v. 30, n. 2, p. 555, doi. 10.1007/s11274-013-1475-1

By:

Teresa Infanta S, Antony;
Nisshanthini, S.;
Palaniswamy, M.;
Angayarkanni, J.

Publication type:

Article

Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15986, doi. 10.3390/ijms232415986

By:

Ishihara, Yuka;
Nakamura, Kiyoshiro;
Nakagawa, Shunsuke;
Okamoto, Yasuhiro;
Yamamoto, Masatatsu;
Furukawa, Tatsuhiko;
Kawahara, Kohichi

Publication type:

Article

Recurrent Translocations in Topoisomerase Inhibitor-Related Leukemia Are Determined by the Features of DNA Breaks Rather Than by the Proximity of the Translocating Genes.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9824, doi. 10.3390/ijms23179824

By:

Lomov, Nikolai A.;
Viushkov, Vladimir S.;
Ulianov, Sergey V.;
Gavrilov, Alexey A.;
Alexeyevsky, Daniil A.;
Artemov, Artem V.;
Razin, Sergey V.;
Rubtsov, Mikhail A.

Publication type:

Article

AK-I-190, a New Catalytic Inhibitor of Topoisomerase II with Anti-Proliferative and Pro-Apoptotic Activity on Androgen-Negative Prostate Cancer Cells.

Published in:

International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 11246, doi. 10.3390/ijms222011246

By:

Jeon, Kyung-Hwa;
Park, Seojeong;
Jang, Hae Jin;
Hwang, Soo-Yeon;
Shrestha, Aarajana;
Lee, Eung-Seok;
Kwon, Youngjoo

Publication type:

Article

Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 1, p. 352, doi. 10.3390/ijms21010352

By:

Sergei, Boichuk;
Pavel, Dunaev;
Aigul, Galembikova;
Firyuza, Bikinieva;
Ilmira, Nurgatina;
Ilshat, Mustafin;
Aida, Aukhadieva;
Refat, Kurtasanov;
Natalia, Andriutsa;
Elena, Shagimardanova;
Vera, Gorbunova

Publication type:

Article